DRDGOLD Limited filings document foreign private issuer disclosures for a South African gold company focused on surface tailings retreatment. Form 6-K reports cover operating updates, gold production and sales metrics, ore milled, yield, revenue, operating profit, adjusted EBITDA, cash costs, interim results, and cash dividend declarations.
The company’s filings also disclose material events affecting ERGO operations, including wage negotiations and labor matters, as well as renewable-energy arrangements connected to mine power supply. Governance filings include annual general meeting results, shareholder voting outcomes, auditor appointments, director elections, and other resolutions for DRDGOLD’s JSE, A2X, and NYSE-traded securities.
DRDGOLD LTD (DRD) reported that Dean Lindecke, General Manager Ergo Ops., had 20,060 deferred shares granted under the Company’s Single Incentive Plan vest on August 13, 2026 and settle one-for-one into Ordinary Shares for no consideration.
Following this vesting, 20,060 Ordinary Shares were sold on the reporting person’s behalf in a pooled sale conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share, translated from an average sale price of ZAR 44.4764 per share. After these transactions, the reporting person held 94,415 deferred shares, with no Rule 10b5-1 trading plan reported.
DRDGOLD LTD (DRD) reported that Financial Manager FWGR Ops. Laas Lihan exercised and sold equity-based awards. On August 13, 2026, 9,029 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration under the Single Incentive Plan. A pooled sale then disposed of 9,029 Ordinary Shares on August 31 and September 1, 2026 at an average of $2.7545 (ZAR 44.4764) per share. No Rule 10b5-1 trading plan is reported.
DRDGOLD LTD (DRD) reports that officer Mashatola Mpho exercised 11,721 Deferred Shares on August 13, 2026, which vested under the Company’s Single Incentive Plan and were settled one-for-one into Ordinary Shares for no consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,275 Ordinary Shares, with the remaining 6,446 Ordinary Shares retained in the reporting person’s own name. Following these events, the reporting person holds 72,900 Deferred Shares; no Rule 10b5-1 trading plan is reported.
DRDGOLD LTD (DRD) reports that Financial Manager Ergo Ops. Ryno Bornman exercised previously awarded deferred equity and sold part of the resulting stake. On August 13, 2026, 12,198 Deferred Shares vested and were settled into the same number of Ordinary Shares for no cash consideration. A subsequent pooled sale on August 31 and September 1, 2026 disposed of 5,490 Ordinary Shares at $2.7545 per share, with the remaining 6,708 Ordinary Shares transferred into and retained in Bornman’s own name. No Rule 10b5-1 trading plan is reported.
DRDGOLD LTD (DRD) reports that Kevin Kruger, Head of Technical Services, had 16,801 Deferred Shares vest on August 13, 2026 and settle into an equal number of Ordinary Shares for no consideration. In a pooled sale on August 31 and September 1, 2026, 7,561 of these Ordinary Shares were sold at an average price of $2.7545 per share, with 9,240 Ordinary Shares transferred to and retained in his name. Following these transactions, Kruger holds 143,927 Deferred Shares directly. No Rule 10b5-1 trading plan is reported.
DRDGOLD LTD (DRD) Chief Financial Officer Henriette Hooijer reported transactions in company equity awards and shares. On August 13, 2026, 18,472 Deferred Shares granted under the Single Incentive Plan vested and were settled on a one-for-one basis into Ordinary Shares for no consideration, and Hooijer acquired 18,472 Ordinary Shares. A pooled sale then disposed of 8,313 of those Ordinary Shares on August 31 and September 1, 2026 at an average price of $2.7545 per share (converted from South African rand), with the remaining 10,159 Ordinary Shares retained in her name. Following these events, she held 110,965 Deferred Shares, and no Rule 10b5-1 trading plan is reported.
DRDGOLD LTD (DRD) insider Daniel Pretorius, the Chief Executive Officer and a director, reported transactions involving 35,537 shares linked to previously awarded Deferred Shares. On August 13, 2026, 35,537 Deferred Shares vested and were settled one-for-one into Ordinary Shares for no consideration, and a pooled sale of 35,537 Ordinary Shares was later conducted on August 31 and September 1, 2026 at an average price of $2.7545 per share equivalent to ZAR 44.4764. No Rule 10b5-1 trading plan is reported.
DRDGOLD Limited (DRD) reports dealings in its securities following the vesting of deferred share awards under its Single Incentive Plan and Deferred Share Plan. On August 13, 2026, a portion of awards granted on August 12, 2025 vested and was settled in DRDGOLD ordinary shares at a zero-exercise price.
Certain participants, including executive directors, a prescribed officer, the company secretary and directors of major subsidiaries, elected to sell all or part of their vested shares through a pooled on‑market sale conducted by an independent third party on August 31 and September 1, 2026. Proceeds were distributed to each participant in proportion to the number of DRDGOLD shares sold, with prior clearance to deal obtained from the board chairman and interests described as direct beneficial.
DRDGOLD Limited (DRD) reports planned changes to its Audit Committee leadership aligned with its 2026 Annual General Meeting (2026 AGM). Non-executive director Johan Holtzhausen will step down from the board at the conclusion of the 2026 AGM, following a previously communicated tenure review.
The board has resolved that Charmel Flemming, an independent non-executive director since 1 August 2020, will become chair of the Audit Committee from the conclusion of the 2026 AGM. She is a Chartered Accountant with more than 15 years’ experience in financial services, and the board states it is satisfied she has the qualifications and expertise to discharge the responsibilities of Audit Committee chair.
DRDGOLD Limited (DRD) reports that, under its Single Incentive Plan incorporating the Deferred Share Plan (DSP), several directors, prescribed officers and the company secretary have accepted annual deferred share awards. The awards carry a zero exercise price and are settled in DRDGOLD ordinary shares on vesting, subject to continued employment and DSP rules. The deemed price per DRDGOLD share for these awards is R36.15, based on the 7‑trading‑day volume weighted average price on the award date of 12 August 2026. Key participants include CEO Niël Pretorius with 163,530 deferred shares (vesting 12 August 2031) and CFO Henriette Hooijer with 74,019 deferred shares (also vesting 12 August 2031), alongside other senior executives and officers with vesting dates in 2029 or 2031.